Autoimmune Hemolytic Anemia

References (3)

1. Nazan S, Suar ÇK, Emine Z, Sema Aylan G. Management of autoimmune hemolytic anemia in children and adolescents: a single center experience.Turk J Hemato 2011;28:198-205 2. Fere W, Gregory, Guttmacher AC. Genomics and the multifactorial nature of human autoimmune disaese. NEJM 2011;365:1612-23 3. Özsoylu Ş. Is every immune hrombocytopenia. Idıopathic thrombocytopenic purpura. Acta Paediatrica 2004;93: 1129-1130 4. Özsoylu Ş, İrken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Hematol 1989;42: 431-435 1. Agarwal B. Autoimmune hemolytic anemia. 1998; 65: 663- 668 2. Collins PW, Newland AC. Treatment modalities of autoimmune blood disorders. 1992; 29: 64-74 3. Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY. Clinical features and outcomes of autoimmune hemolytic anemia: A retrospective analysis of 32 cases. Korean J Hematol 2011; 46: 111-117 4. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, de Saint Basile G, Delaunay J, Schwarz K, Casanova JL, Blanche S, Fischer A. Autoimmunity in Wiskott-Aldrich syndrome: Risk factors, clinical features and outcome in a single-center cohort of 55 patients. Pediatrics 2003; 111: 622-627 5. Eddou H, Helissey C, Konopacki J, Souleau B, de Revel T, Malfuson JV. Evans syndrome: Be careful of over-diagnosis. Rev Med Interne 2012; 33 (3): 155-158 6. Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Williams Hematology. Sixth edition 2001,
2. McGraw-Hill Companies, New York 7. Philip Lanzkowsky. Manual of Pediatric Hematology and Oncology, Fifth edition, 2011
3. Academic Press, London